medigraphic.com
SPANISH

MediSur

ISSN 1727-897X (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 6

<< Back Next >>

Medisur 2021; 19 (6)

p.K952L polymorphism detection in Cuban patients with Wilson's disease

Clark FY, Ruenes DC, García BEF, Feoktistova L, Roblejo BH, Morales PE
Full text How to cite this article

Language: Spanish
References: 23
Page: 917-923
PDF size: 219.53 Kb.


Key words:

hepatolenticular degeneration genes, blood coagulation disorders, polymorphism genetic, genetic, pathology molecular.

ABSTRACT

Background Wilson's disease is a rare entity with an autosomal recessive inheritance pattern, due to mutations in the ATP7B gene, which causes the accumulation of copper in tissues and organs. More than 800 polymorphisms are reported in the literature.
Objective to identify the p.K952L polymorphism in Cuban patients with a presumptive clinical diagnosis of Wilson's disease.
Methods a descriptive study was carried out at the Medical Genetics National Center and the Gastroenterology National Institute, which included 35 patients with a Wilson's disease clinical diagnosis. DNA extraction was by saline precipitation technique; and the amplification of the fragment of interest, by means of the Polymerase Chain Reaction technique. In addition, the Simple Chain Conformational Polymorphism technique was used to determine the conformational changes and the presence of the p.K952L polymorphism.
Results in exon 12 the conformational changes called b and c were identified, which corresponded to the polymorphism p.K952L in the heterozygous and homozygous state, respectively. The allelic frequency of the p.K952L polymorphism was 38.6%. The most frequent manifestations in patients with this polymorphism were liver.
Conclusion The p.K952L polymorphism was identified in 21 Cuban patients with a clinical diagnosis of Wilson's disease, which makes it possible to extend molecular studies by indirect methods.


REFERENCES

  1. Hedera P. Update on the clinical managementof Wilson’s disease. Appl Clin Genet. 2017 ; 10:9-19.

  2. McCann C, Jayakanthan S, Siotto M, Yang N,Osipova M, Squitti R, et al. Single nucleotidepolymorphisms in the human ATP7B gene modifythe properties of the ATP7B protein. Metallomics.2019 ; 11 (6): 1128-39.

  3. Espinós C, Ferenci P. Are the new genetic toolsfor diagnosis of Wilson disease helpful in clinicalpractice?. JHEP Reports. 2020 ; 2 (4): 100114.

  4. Wallace DF, Dooley JS. ATP7B variantpenetrance explains differences between geneticand clinical prevalence estimates for Wilsondisease. Hum Genet. 2020 ; 139 (8): 1065-75.

  5. Hua R, Hua F, Jiao Y, Pan, Yang X, Peng S, et al.Mutational analysis of ATP7B in Chinese Wilsondisease patients. Am J Transl Res. 2016 ; 8 (6):2851-61.

  6. Kudryavtsev A, Gornostaeva E, Voevoda M,Maximov V, Krovalenko S. The frequency ofmutations in the ATP7B gene in Russia. MetaGene. 2017 ; 13: 173-6.

  7. Chin L, Tze E, Fu T, Ta L, Pang S, Jan C.Development of a high-resolution meltingm e t h o d f o r t h e s c r e e n i n g o f W i l s o ndisease-related ATP7B gene mutations. Clin ChimActa. 2010 ; 411 (17-18): 1223-31.

  8. Paradisi I, De Freitas L, Arias S. Most frequentmutation c.3402delC (p.Ala1135GlnfsX13) amongWilson disease patients in Venezuela has a widedistribution and two old origins. Eur J Med Genet.2015 ; 58 (2): 59-65.

  9. Miller SA, Dykes DD, Polesky HF. A simplesalting out procedure for extracting DNA fromhuman nucleated cells. Nucleic Acids Res. 1988 ;16 (3): 1215.

  10. Cong L, Lin Q, Wen H, Chi T. New mutationsand polymorphisms of the ATP7B gene insporadic Wilson disease. Eur J Med Genet. 2014 ;57 (9): 498-502.

  11. Zali N, Mohebbi S, Esteghamat S, Chiani M,Haghighi M. Prevalence of ATP7B gene mutationsin Iranian patients with Wilson disease. HepatMon. 2011 ; 11 (11): 890-4.

  12. Todorov T, Savov A, Jelev H, Panteleeva E,Konstantinova D, Krustev Z, et al. Spectrum ofmutations in the Wilson disease gene (ATP7B) inthe Bulgarian population. Clin Genet. 2005 ; 68(5): 474-6.

  13. Chang T, Fuu T, Jer W, Jang C, Cheng L,Shuan L. Mutation Analysis of Wilson Disease inTaiwan and Description of Six New Mutations.Hum Mutat. 1998 ; 12 (6): 370-6.

  14. Roy S, McCann C, Ralle M, Ray K, Ray J,Lutsenk S, Jayakanthan S. Analysis of Wilsondisease mutations revealed that interactionsbetween different ATP7B mutants modify theirproperties. Sci Rep. 2020 ; 10: 13487.

  15. Shim J, Yang H, Moon J, Chang J, Ko J, Park S,et al. Multiplex Ligation-dependent ProbeAmplification Analysis Subsequent to Direct DNAFull Sequencing for Identifying ATP7B Mutationsand Phenotype Correlations in Children withWilson Disease. J Korean Med Sci. 2018 ; 33 (26):e177.

  16. Tuan L, Tue T, Nga H, Quoc D, Tu C, Huy T, etal. Genetic analysis of 55 northern Vietnamesepatients with Wilson disease: seven novelmutations in ATP7B. J Genet. 2017 ; 96 (6): 933-9.

  17. Collet C, Laplanche JL, Page J, Morel H,Woimant F, Poujois A. High genetic carrierfrequency of Wilson’s disease in France:discrepancies with clinical prevalence. BMC MedGenet. 2018 ; 19 (1): 143.

  18. Kumari N, Kumar A, Thapa B, Modi M, Pal A,Prasad R. Characterization of mutation spectrumand identification of novel mutations in ATP7Bgene from a cohort of Wilson disease patients:Functional and therapeutic implications. HumMutat. 2018 ; 39 (12): 1926-41.

  19. Clark Y, Collazo T, Ruenes C, García E, Robaina Z, Fragoso T, et al. Detection ofconformationals shift and mutation in the exon 8of the atp7b gene in Cubans patients with Wilsondisease. Biotecnol Apl [revista en Internet]. 2011[ cited 17 Sep 2020 ] ; 28 (2): [aprox. 9p].A v a i l a b l e f r o m :http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522011000200004.

  20. Feoktistova L, Ruenes C, García E, Roblejo H,Morales E, Clark Y. Coagulation disorders inCuban patients with a clinical diagnosis ofWilson's disease. Medisur [revista en Internet].2020 [ cited 17 Sep 2020 ] ; 18 (2): [aprox. 10p].A v a i l a b l e f r o m :http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2020000200171&lng=es&nrm=iso&tlng=es.

  21. Clark Y, Collazo T, Ruenes C, García B, GarciaE, Robaina Z, Fragoso T. Molecular analysis in theexon 2 of atp7b gene in cubans patients withWilson disease. Rev Haban Cienc Méd [revista enInternet]. 2011 [ cited 17 Sep 2020 ] ; 10 (3):[ a p r o x . 6 p ] . A v a i l a b l e f r o m :http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2011000300004.

  22. Clark Y, Ruenes C, García E, Roblejo H,Robaina Z, Morales E. p. K832R and p. Análisis delos polimorfismos p. K832R y p. T991T enpacientes cubanos con diagnóstico clínico de laenfermedad de Wilson. Rev Haban Cienc Méd[revista en Internet]. 2017 [ cited 17 Sep 2020 ] ;16 (2): [aprox. 11p]. Available from:http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S1729-519X2017000200004&lng=es&nrm=iso&tlng=en.

  23. Clark Y, Ruenes C, García EF, Roblejo H, ClarkI, Jay O, Collazo T. Polimorfismo p.L456V,presencia en pacientes cubanos con diagnósticoclínico presuntivo de la enfermedad de Wilson.Rev Gastroenterol Mex [revista en Internet].2019 [ cited 17 Sep 2020 ] ; 84 (2): [aprox. 12p].A v a i l a b l e f r o m :http://www.revistagastroenterologiamexico.org/es-polimorfismo-p-l456v-presencia-pacientes-cubanos-articulo-S0375090618300946.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Medisur. 2021;19